Protective effect of starch-stabilized selenium nanoparticles against the hepato-renal melamine-induced toxicity in male albino rats

15 July 2021, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Melamine and its analogues are illegally added to falsify the content of protein in food products. The elevated concentrations of these compounds cause harmful effects in humans and animals. In this contribution, the potential ability of synthesized starch-stabilized selenium nanoparticles (Se-NPs@starch) towards inhibiting the toxicity of melamine on the liver and kidneys has been systematically investigated. The Se-NPs@starch were characterized by XPS analysis, EDS mapping analysis, TEM, and FT-IR. Starch plays a crucial role in the stabilization and dispersion of Se NPs, as noticed from the TEM and EDS investigations. Furthermore, the atomic ratio of Se distribution over starch surface is approximately 1.67%. To evaluate the activity of Se-NPs@starch, this study was conducted on four groups of adult male rats. Group I (the control group), group II received Se-NPs@starch, group III received melamine, whereas group IV received melamine and Se-NPs@starch. The results reveal a significant alteration in the histoarchitecture of both hepatic and renal tissues induced by melamine. While melamine induces severe toxic effects on the hepatic and renal tissues, the administration of Se-NPs@starch results in remarkable protection of rats against melamine-induced toxicity. Collectively, the affordable starch-stabilized Se-NPs have a potent biological activity, making them auspicious candidates for biomedical applications.

Keywords

Melamine-toxicity
Se-NPs@starch
Immobilization

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.